- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 10 residues within 4Å:- Chain A: A.157, L.158, N.159, R.195, N.240, S.241, T.242
- Chain E: K.183, I.211
- Ligands: NAG-NAG-BMA-MAN-MAN.1
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.26: 10 residues within 4Å:- Chain A: K.183, I.211
- Chain C: A.157, L.158, N.159, R.195, N.240, S.241, T.242
- Ligands: NAG-NAG-BMA-MAN-MAN.25
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.50: 10 residues within 4Å:- Chain C: K.183, I.211
- Chain E: A.157, L.158, N.159, R.195, N.240, S.241, T.242
- Ligands: NAG-NAG-BMA-MAN-MAN.49
No protein-ligand interaction detected (PLIP)- 3 x NAG- GAL- NAG- GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-6)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-GAL-NAG-GAL-SIA.3: 14 residues within 4Å:- Chain A: Y.92, G.128, T.129, S.130, S.131, W.147, T.149, H.177, S.187, L.188, R.216, D.219, I.220, S.222
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:L.188, A:W.147, A:T.149, A:L.188
- Water bridges: A:D.184, A:T.129, A:T.129, A:S.131
- Hydrogen bonds: A:R.216, A:D.219, A:Y.92, A:T.129, A:S.131, A:S.222, A:S.222
NAG-GAL-NAG-GAL-SIA.27: 14 residues within 4Å:- Chain C: Y.92, G.128, T.129, S.130, S.131, W.147, T.149, H.177, S.187, L.188, R.216, D.219, I.220, S.222
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:L.188, C:W.147, C:T.149, C:L.188
- Water bridges: C:D.184, C:T.129, C:T.129, C:S.131
- Hydrogen bonds: C:R.216, C:D.219, C:Y.92, C:T.129, C:S.131, C:S.222, C:S.222
NAG-GAL-NAG-GAL-SIA.51: 14 residues within 4Å:- Chain E: Y.92, G.128, T.129, S.130, S.131, W.147, T.149, H.177, S.187, L.188, R.216, D.219, I.220, S.222
11 PLIP interactions:11 interactions with chain E- Hydrophobic interactions: E:L.188, E:W.147, E:T.149, E:L.188
- Water bridges: E:D.184, E:T.129, E:T.129, E:S.131
- Hydrogen bonds: E:R.216, E:D.219, E:Y.92, E:T.129, E:S.131, E:S.222, E:S.222
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 3 residues within 4Å:- Chain A: E.56, N.57, Y.88
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.57
- Water bridges: A:N.57
NAG.5: 4 residues within 4Å:- Chain A: N.39, N.279, V.291, N.292
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.279, A:V.291, A:N.292
- Water bridges: A:V.291
NAG.6: 2 residues within 4Å:- Chain A: N.127, R.249
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.127, A:R.249
NAG.7: 6 residues within 4Å:- Chain A: N.32, T.34, T.312
- Chain B: L.52
- Ligands: PG4.8, PEG.21
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.32, A:T.312
NAG.28: 3 residues within 4Å:- Chain C: E.56, N.57, Y.88
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.57
- Water bridges: C:N.57
NAG.29: 4 residues within 4Å:- Chain C: N.39, N.279, V.291, N.292
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:N.279, C:V.291, C:N.292
- Water bridges: C:V.291
NAG.30: 2 residues within 4Å:- Chain C: N.127, R.249
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.127, C:R.249
NAG.31: 6 residues within 4Å:- Chain C: N.32, T.34, T.312
- Chain D: L.52
- Ligands: PG4.32, PEG.45
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.32, C:T.312
NAG.52: 3 residues within 4Å:- Chain E: E.56, N.57, Y.88
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:N.57
- Water bridges: E:N.57
NAG.53: 4 residues within 4Å:- Chain E: N.39, N.279, V.291, N.292
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:N.279, E:V.291, E:N.292
- Water bridges: E:V.291
NAG.54: 2 residues within 4Å:- Chain E: N.127, R.249
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:N.127, E:R.249
NAG.55: 6 residues within 4Å:- Chain E: N.32, T.34, T.312
- Chain F: L.52
- Ligands: PG4.56, PEG.69
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:N.32, E:T.312
- 6 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
PG4.8: 11 residues within 4Å:- Chain A: H.12, T.31, N.32, T.312
- Chain B: V.18, D.19, G.20, W.21, I.45
- Ligands: NAG.7, PEG.21
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:T.31, A:N.32, B:G.20
PG4.13: 8 residues within 4Å:- Chain A: F.288, R.301
- Chain B: R.54, L.55, W.92, E.103
- Chain E: I.23
- Chain F: Y.94
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain E- Hydrogen bonds: A:R.301, E:I.23
- Water bridges: A:R.301
PG4.32: 11 residues within 4Å:- Chain C: H.12, T.31, N.32, T.312
- Chain D: V.18, D.19, G.20, W.21, I.45
- Ligands: NAG.31, PEG.45
3 PLIP interactions:1 interactions with chain D, 2 interactions with chain C- Hydrogen bonds: D:G.20, C:T.31, C:N.32
PG4.37: 8 residues within 4Å:- Chain A: I.23
- Chain B: Y.94
- Chain C: F.288, R.301
- Chain D: R.54, L.55, W.92, E.103
3 PLIP interactions:2 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: C:R.301, A:I.23
- Water bridges: C:R.301
PG4.56: 11 residues within 4Å:- Chain E: H.12, T.31, N.32, T.312
- Chain F: V.18, D.19, G.20, W.21, I.45
- Ligands: NAG.55, PEG.69
3 PLIP interactions:2 interactions with chain E, 1 interactions with chain F- Hydrogen bonds: E:T.31, E:N.32, F:G.20
PG4.61: 8 residues within 4Å:- Chain C: I.23
- Chain D: Y.94
- Chain E: F.288, R.301
- Chain F: R.54, L.55, W.92, E.103
3 PLIP interactions:2 interactions with chain E, 1 interactions with chain C- Hydrogen bonds: E:R.301, C:I.23
- Water bridges: E:R.301
- 27 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.9: 5 residues within 4Å:- Chain A: K.77, W.78, D.79, G.110, S.259
Ligand excluded by PLIPEDO.10: 1 residues within 4Å:- Chain A: S.48
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain A: P.93, Y.94, I.217, R.223
- Chain C: K.201
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain A: C.299, R.301
- Chain B: T.59, N.60, K.62
Ligand excluded by PLIPEDO.15: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPEDO.16: 1 residues within 4Å:- Chain B: S.29
Ligand excluded by PLIPEDO.17: 3 residues within 4Å:- Chain B: H.26, N.146, R.153
Ligand excluded by PLIPEDO.18: 2 residues within 4Å:- Chain B: G.155, D.158
Ligand excluded by PLIPEDO.19: 5 residues within 4Å:- Chain B: D.79, K.82, Y.83
- Chain D: H.64, Q.65
Ligand excluded by PLIPEDO.33: 5 residues within 4Å:- Chain C: K.77, W.78, D.79, G.110, S.259
Ligand excluded by PLIPEDO.34: 1 residues within 4Å:- Chain C: S.48
Ligand excluded by PLIPEDO.35: 5 residues within 4Å:- Chain C: P.93, Y.94, I.217, R.223
- Chain E: K.201
Ligand excluded by PLIPEDO.38: 5 residues within 4Å:- Chain C: C.299, R.301
- Chain D: T.59, N.60, K.62
Ligand excluded by PLIPEDO.39: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPEDO.40: 1 residues within 4Å:- Chain D: S.29
Ligand excluded by PLIPEDO.41: 3 residues within 4Å:- Chain D: H.26, N.146, R.153
Ligand excluded by PLIPEDO.42: 2 residues within 4Å:- Chain D: G.155, D.158
Ligand excluded by PLIPEDO.43: 5 residues within 4Å:- Chain D: D.79, K.82, Y.83
- Chain F: H.64, Q.65
Ligand excluded by PLIPEDO.57: 5 residues within 4Å:- Chain E: K.77, W.78, D.79, G.110, S.259
Ligand excluded by PLIPEDO.58: 1 residues within 4Å:- Chain E: S.48
Ligand excluded by PLIPEDO.59: 5 residues within 4Å:- Chain A: K.201
- Chain E: P.93, Y.94, I.217, R.223
Ligand excluded by PLIPEDO.62: 5 residues within 4Å:- Chain E: C.299, R.301
- Chain F: T.59, N.60, K.62
Ligand excluded by PLIPEDO.63: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPEDO.64: 1 residues within 4Å:- Chain F: S.29
Ligand excluded by PLIPEDO.65: 3 residues within 4Å:- Chain F: H.26, N.146, R.153
Ligand excluded by PLIPEDO.66: 2 residues within 4Å:- Chain F: G.155, D.158
Ligand excluded by PLIPEDO.67: 5 residues within 4Å:- Chain B: H.64, Q.65
- Chain F: D.79, K.82, Y.83
Ligand excluded by PLIP- 12 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.12: 2 residues within 4Å:- Chain A: R.315
- Chain B: A.7
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.315, A:R.315
PEG.20: 4 residues within 4Å:- Chain A: R.263
- Chain B: E.69, F.70, S.71
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.71
PEG.21: 7 residues within 4Å:- Chain A: T.312
- Chain B: I.45, I.48, N.49, L.52
- Ligands: NAG.7, PG4.8
No protein-ligand interaction detected (PLIP)PEG.22: 6 residues within 4Å:- Chain B: G.8, F.9, E.11, M.133, G.134, N.135
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.11
PEG.36: 2 residues within 4Å:- Chain C: R.315
- Chain D: A.7
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:R.315, C:R.315
PEG.44: 4 residues within 4Å:- Chain C: R.263
- Chain D: E.69, F.70, S.71
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:S.71
PEG.45: 7 residues within 4Å:- Chain C: T.312
- Chain D: I.45, I.48, N.49, L.52
- Ligands: NAG.31, PG4.32
No protein-ligand interaction detected (PLIP)PEG.46: 6 residues within 4Å:- Chain D: G.8, F.9, E.11, M.133, G.134, N.135
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:E.11
PEG.60: 2 residues within 4Å:- Chain E: R.315
- Chain F: A.7
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:R.315, E:R.315
PEG.68: 4 residues within 4Å:- Chain E: R.263
- Chain F: E.69, F.70, S.71
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:S.71
PEG.69: 7 residues within 4Å:- Chain E: T.312
- Chain F: I.45, I.48, N.49, L.52
- Ligands: NAG.55, PG4.56
No protein-ligand interaction detected (PLIP)PEG.70: 6 residues within 4Å:- Chain F: G.8, F.9, E.11, M.133, G.134, N.135
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:E.11
- 6 x SO4: SULFATE ION(Non-functional Binders)
SO4.23: 5 residues within 4Å:- Chain B: M.133, K.139
- Chain D: R.127, H.159, N.160
5 PLIP interactions:2 interactions with chain B, 3 interactions with chain D- Hydrogen bonds: B:Y.141, D:N.160
- Salt bridges: B:K.139, D:R.127, D:H.159
SO4.24: 5 residues within 4Å:- Chain B: G.13, W.14, E.15, G.16, R.25
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.15, B:G.16
- Salt bridges: B:R.25
SO4.47: 5 residues within 4Å:- Chain D: M.133, K.139
- Chain F: R.127, H.159, N.160
5 PLIP interactions:2 interactions with chain D, 3 interactions with chain F- Hydrogen bonds: D:Y.141, F:N.160
- Salt bridges: D:K.139, F:R.127, F:H.159
SO4.48: 5 residues within 4Å:- Chain D: G.13, W.14, E.15, G.16, R.25
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:E.15, D:G.16
- Salt bridges: D:R.25
SO4.71: 5 residues within 4Å:- Chain B: R.127, H.159, N.160
- Chain F: M.133, K.139
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain F- Hydrogen bonds: B:N.160, F:Y.141
- Salt bridges: B:R.127, B:H.159, F:K.139
SO4.72: 5 residues within 4Å:- Chain F: G.13, W.14, E.15, G.16, R.25
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:E.15, F:G.16
- Salt bridges: F:R.25
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Thompson, A.J. et al., Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site. Cell Host Microbe (2024)
- Release Date
- 2024-02-14
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2 chain: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- GAL- NAG- GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-6)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 27 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 12 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 6 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Thompson, A.J. et al., Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site. Cell Host Microbe (2024)
- Release Date
- 2024-02-14
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2 chain: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B